KPTI logo

Karyopharm Therapeutics (KPTI) Long Term Debt

Annual Long Term Debt

$173.71 M
-$2.49 M-1.42%

December 31, 2023


Summary


Performance

KPTI Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPTIbalance sheetmetrics:

Quarterly Long Term Debt

$190.59 M
-$1.49 M-0.78%

September 30, 2024


Summary


Performance

KPTI Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPTIbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

KPTI Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.4%-0.8%
3 y3 years+34.4%+6.6%
5 y5 years+69.2%+56.7%

KPTI Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.5%at low-0.8%+10.2%
5 y5-year-2.5%+41.2%-0.8%+54.9%
alltimeall time-2.5%+69.2%-0.8%+85.7%

Karyopharm Therapeutics Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$190.59 M(-0.8%)
Jun 2024
-
$192.09 M(+11.0%)
Mar 2024
-
$173.01 M(-0.4%)
Dec 2023
$173.71 M(-1.4%)
$173.71 M(-0.4%)
Sep 2023
-
$174.37 M(-0.4%)
Jun 2023
-
$175.00 M(-0.4%)
Mar 2023
-
$175.62 M(-0.3%)
Dec 2022
$176.20 M(-1.2%)
$176.20 M(-0.3%)
Sep 2022
-
$176.76 M(-0.3%)
Jun 2022
-
$177.28 M(-0.3%)
Mar 2022
-
$177.78 M(-0.3%)
Dec 2021
$178.26 M
$178.26 M(-0.3%)
DateAnnualQuarterly
Sep 2021
-
$178.73 M(-0.2%)
Jun 2021
-
$179.10 M(-0.2%)
Mar 2021
-
$179.45 M(+38.9%)
Dec 2020
$129.21 M(+5.0%)
$129.21 M(+1.3%)
Sep 2020
-
$127.60 M(+1.2%)
Jun 2020
-
$126.05 M(+1.2%)
Mar 2020
-
$124.52 M(+1.2%)
Dec 2019
$123.06 M(+19.9%)
$123.06 M(+1.2%)
Sep 2019
-
$121.61 M(+1.2%)
Jun 2019
-
$120.21 M(+1.2%)
Mar 2019
-
$118.83 M(+15.7%)
Dec 2018
$102.66 M
$102.66 M

FAQ

  • What is Karyopharm Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics annual long term debt year-on-year change?
  • What is Karyopharm Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics quarterly long term debt year-on-year change?

What is Karyopharm Therapeutics annual long term debt?

The current annual long term debt of KPTI is $173.71 M

What is the all time high annual long term debt for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high annual long term debt is $178.26 M

What is Karyopharm Therapeutics annual long term debt year-on-year change?

Over the past year, KPTI annual long term debt has changed by -$2.49 M (-1.42%)

What is Karyopharm Therapeutics quarterly long term debt?

The current quarterly long term debt of KPTI is $190.59 M

What is the all time high quarterly long term debt for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high quarterly long term debt is $192.09 M

What is Karyopharm Therapeutics quarterly long term debt year-on-year change?

Over the past year, KPTI quarterly long term debt has changed by -$1.49 M (-0.78%)